title: Striatal dopamine function in a family with multiple SCA-3 phenotypes.
abstract: We present single photon emission computed tomography (SPECT) studies using 123IFP-CIT (DAT scan) and 123I-IBZM imaging, performed on four members of a family with genetically proven spinocerebellar ataxia type 3 (SCA-3). DAT scan showed significant asymmetric decreased binding in the striatum in the two members with predominant parkinsonian phenotype, with mild and symmetric decreased binding in the member with the cerebellar phenotype, and normal in the asymptomatic member. The IBZM SPECT studies showed mild and asymmetrical reduction of the striatal dopamine D2 receptor density (parkinsonian members). SCA-3 can present with a levodopa responsive parkinsonism phenotype, and an abnormal DAT scan showing predominant impairment of presynaptic dopamine function.
authors.affiliation: Department of Neurology, Hospital General Yagüe, Avda Cid 96, 09005, Burgos, Spain. esthercubo@gmail.com
authors.forename: Esther
authors.initials: E
authors.lastname: Cubo
authors.forename: Mateo Diez
authors.initials: MD
authors.lastname: López
authors.forename: Jon Infante
authors.initials: JI
authors.lastname: Ceberio
authors.forename: Isabel Lanchas
authors.initials: IL
authors.lastname: Alfonso
authors.forename: Begoña Miguel
authors.initials: BM
authors.lastname: Martinez
authors.forename: José
authors.initials: J
authors.lastname: Berciano
authors.forename: Fernando
authors.initials: F
authors.lastname: Iglesias
authors.forename: José A
authors.initials: JA
authors.lastname: Obeso
mesh_terms: D000368:Aged; D001549:Benzamides; D003342:Corpus Striatum / Q000000981:diagnostic imaging* / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism*; D005260:Female; D006801:Humans; D017827:Machado-Joseph Disease / Q000000981:diagnostic imaging* / Q000378:metabolism / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D010375:Pedigree; D010641:Phenotype; D011759:Pyrrolidines; D019275:Radiopharmaceuticals; D017448:Receptors, Dopamine D2 / Q000378:metabolism*; D015899:Tomography, Emission-Computed, Single-Photon; D014326:Tropanes
chemical_list: D001549:Benzamides; D011759:Pyrrolidines; D019275:Radiopharmaceuticals; D017448:Receptors, Dopamine D2; D014326:Tropanes; C087552:2-carbomethoxy-8-(3-fluoropropyl)-3-(4-iodophenyl)tropane; C055743:3-iodo-2-hydroxy-6-methoxy-N-((1-ethyl-2-pyrrolidinyl)methyl)benzamide; D004298:Dopamine
references.citation: Mov Disord. 1998 May;13(3):438-45
references.pmid: 9613734
references.citation: J Neurol Sci. 2003 Sep 15;213(1-2):25-8
references.pmid: 12873751
references.citation: Mov Disord. 2000 May;15(3):503-510
references.pmid: 28470733
references.citation: J Nucl Med. 2002 Feb;43(2):153-9
references.pmid: 11850478
references.citation: Ann Neurol. 1998 Mar;43(3):288-96
references.pmid: 9506544
references.citation: J Nucl Med. 2000 Jun;41(6):994-8
references.pmid: 10855623
references.citation: Eur J Nucl Med Mol Imaging. 2004 Aug;31(8):1119-27
references.pmid: 15064872